Verition Fund Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29,314	Closed	-$468K	–	2321
2025 Q4	$468K	Sell	29,314 -114,230	-80%	-$1.62M	﹤0.01%	2711
2025 Q3	$1.59M	Buy	143,544 +112,600	+364%	+$1.23M	0.01%	2162
2025 Q2	$262K	Buy	+30,944	New	+$248K	﹤0.01%	3263
2025 Q1	–	Sell	-83,812	Closed	-$753K	–	3322
2024 Q4	$753K	Buy	83,812 +25,294	+43%	+$206K	﹤0.01%	2217
2024 Q3	$429K	Buy	58,518 +39,583	+209%	+$245K	﹤0.01%	2412
2024 Q2	$108K	Buy	+18,935	New	+$99.7K	﹤0.01%	2722
2023 Q3	–	Sell	-65,500	Closed	-$634K	–	2345
2023 Q2	$634K	Buy	65,500 +27,810	+74%	+$289K	0.01%	1100
2023 Q1	$413K	Buy	37,690 +25,000	+197%	+$220K	0.01%	1353
2022 Q4	$54.8K	Sell	12,690 -1,927	-13%	-$11.2K	﹤0.01%	1883
2022 Q3	$110K	Sell	14,617 -22,001	-60%	-$190K	﹤0.01%	2607
2022 Q2	$368K	Buy	+36,618	New	+$409K	0.01%	1620
2022 Q1	–	Sell	-180,134	Closed	-$2.78M	–	2711
2021 Q4	$4.12M	Buy	+180,134	New	+$4.27M	0.03%	450
2020 Q4	–	Sell	-31,100	Closed	-$458K	–	1092
2020 Q3	$458K	Sell	31,100 -62,508	-67%	-$906K	0.01%	608
2020 Q2	$1.52M	Buy	93,608 +33,555	+56%	+$537K	0.05%	289
2020 Q1	$871K	Buy	60,053 +13,999	+30%	+$247K	0.03%	250
2019 Q4	$933K	Buy	+46,054	New	+$424K	0.02%	471